ATE110363T1 - 1-acyl-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen. - Google Patents

1-acyl-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen.

Info

Publication number
ATE110363T1
ATE110363T1 AT90830256T AT90830256T ATE110363T1 AT E110363 T1 ATE110363 T1 AT E110363T1 AT 90830256 T AT90830256 T AT 90830256T AT 90830256 T AT90830256 T AT 90830256T AT E110363 T1 ATE110363 T1 AT E110363T1
Authority
AT
Austria
Prior art keywords
pyrrolidinones
acyl
learning
substituted
alkyl
Prior art date
Application number
AT90830256T
Other languages
English (en)
Inventor
Fabio Giannessi
Orlando Ghirardi
Domenico Misiti
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE110363T1 publication Critical patent/ATE110363T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90830256T 1989-06-12 1990-06-08 1-acyl-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen. ATE110363T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8948072A IT1231921B (it) 1989-06-12 1989-06-12 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (1)

Publication Number Publication Date
ATE110363T1 true ATE110363T1 (de) 1994-09-15

Family

ID=11264356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90830256T ATE110363T1 (de) 1989-06-12 1990-06-08 1-acyl-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen.

Country Status (8)

Country Link
US (1) US5102896A (de)
EP (1) EP0412058B1 (de)
JP (1) JPH0324054A (de)
AT (1) ATE110363T1 (de)
DE (1) DE69011781T2 (de)
DK (1) DK0412058T3 (de)
ES (1) ES2058874T3 (de)
IT (1) IT1231921B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247698B (it) * 1990-06-21 1994-12-30 Sigma Tau Ind Farmaceuti 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
EP1367056A1 (de) * 1992-07-24 2003-12-03 The Regents Of The University Of California Arzneimittel die den durch AMPA Rezeptoren vermittelten synaptischen Respons erhöhen
EP0730631B1 (de) * 1993-11-25 1999-07-07 WARWICK INTERNATIONAL GROUP LIMITED (Company No. 2982784) Bleichmittelzusammensetzungen
CA2165919A1 (en) * 1994-12-26 1996-06-27 Koichi Katsuyama Agents for inhibiting the production of il-1.beta. and the release of tnf.
CN103910712B (zh) * 2014-04-02 2016-09-07 江南大学 一种过氧化氢活化剂及其应用
CN104032563B (zh) * 2014-05-27 2016-03-23 浙江莱美纺织印染科技有限公司 一种涤纶混纺织物漂白前处理方法
US11878971B2 (en) 2020-12-29 2024-01-23 Huscion Co., Ltd. Piperlongumine-based compound and immuno regulator comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS61229801A (ja) * 1985-04-03 1986-10-14 Taki Chem Co Ltd 植物生長調節剤

Also Published As

Publication number Publication date
US5102896A (en) 1992-04-07
EP0412058A1 (de) 1991-02-06
DK0412058T3 (da) 1994-09-19
EP0412058B1 (de) 1994-08-24
JPH0324054A (ja) 1991-02-01
IT8948072A0 (it) 1989-06-12
IT1231921B (it) 1992-01-15
DE69011781T2 (de) 1995-01-05
DE69011781D1 (de) 1994-09-29
ES2058874T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
BR9713460A (pt) Composição de limpeza lìquida, e, composição alvejante lìquida.
DE10199003I1 (de) Substituierte Thiazolidinionderivate
OA09354A (fr) "Nouveaux dérivés de l'amino pipéridine, de l'amino pyrrolidine et de l'amino perhydroazépine, leurs procédés de préparation, les compositions pharmaceutiques qui les contiennent".
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
DE3378534D1 (en) 5-substituted 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IE893653L (en) Compositions and compounds
ATE110363T1 (de) 1-acyl-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen.
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
ATE129996T1 (de) (pyrrolidin-2-on-1-yl)acetamide zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmezeutische zubereitungen.
MX9202782A (es) Compuesto triciclos y composiciones farmaceuticas que lo contienen.
NZ230503A (en) Substituted beta-diketones and pharmaceutical compositions
DE69115135D1 (de) 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
ATE116855T1 (de) 3-amino-epsilon-caprolactam enthaltende pharmazeutische zusammensetzungen zur verbesserung des lernvermögens und des gedächtnisses.
ATE128461T1 (de) 3-acylamino-2-pyrrolidinone zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen.
FR2549062B1 (fr) Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
JPS6426554A (en) Novel derivative of 1-benzoyl-2-oxo-5-alkoxy pyrrolidine, manufacture, use as drug and composition
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
FR2682952B1 (fr) Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
NO167382C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer.
KR880007502A (ko) 신규의 아미노알카노일-디벤조[d, g][1,3,6]디옥사조신 및 그의 제조방법
JPS6422852A (en) Novel derivative of 1-arylsulfonyl-1,5-dihydro- 2h-pyrrole-2-one, manufacture and intermediate, use as drug and composition
JPS6426553A (en) Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee